Robert Half heads into its July 24 earnings report with short sellers pulling back sharply — yet the ORTEX short score remains elevated, and Goldman Sachs just reaffirmed its Sell rating with the stock already trading above the Street's average target.
The most striking development this week is the retreat in short interest. Shorts have covered aggressively: SI % of free float has dropped from roughly 27% in late June to 22.1% now, a fall of nearly 13% over the past month and 7.6% in the past week alone. That is a meaningful unwind — yet at 22% of free float, the position is still substantial by any standard. Borrow conditions give little urgency to cover further. The cost to borrow is a negligible 0.56%, and availability has actually loosened over the week, running at 166% — meaning there are well over one-and-a-half shares available to borrow for every share currently shorted. That combination points to a deliberate tactical cover rather than a squeeze-driven exit. The ORTEX short score has eased marginally from the mid-74s earlier this week to 73.1, but it still ranks in just the 2nd percentile of the universe — in other words, RHI remains one of the most shorted names across the entire market.
Options positioning flips the tone entirely. Calls are clearly dominating flow right now. The put/call ratio has dropped to 0.39, well below its 20-day average of 0.61, making it one of the most call-heavy readings of the past year — the 52-week low sits at 0.37. As recently as mid-June, the PCR was running above 1.2, a signal of heavy downside hedging. That the ratio has halved in a month, coinciding with the stock's 10% rally, suggests options traders have shifted from protection to positioning for upside into the print. The z-score of -0.74 is not extreme, but the direction of travel is unambiguous.
The Street is skeptical, and Goldman made that explicit on Tuesday. George Tong at Goldman Sachs raised his price target from $23 to $26 — acknowledging the stock's run — but kept his Sell rating intact. That target implies roughly 27% downside from the current $35.65. The consensus mean target across all analysts is $30.78, meaning RHI is already trading above where the average analyst thinks it should be. That is an unusual setup ahead of a report. Most other recent moves cluster in the cautious middle: Barclays at Equal-Weight, BMO at Market Perform, JPMorgan at Neutral. William Blair upgraded to Outperform in April, providing the clearest bull voice. The bull case centers on a potential return to ~$7B in revenues with margins expanding toward 13%, implying EBITDA above $900M if the labor market stabilizes. Bears point to the ongoing weakness in Talent Solutions — down 14% year-on-year last quarter — and guidance that signals a further 10%-14% decline ahead.
On prior earnings reactions, the pattern is consistently punishing. The last three prints each produced a negative next-day move: -5.3%, -3.9%, and -13.1% respectively. The five-day window has been mixed, with modest recovery after some prints but a -9.7% hole after the April report. For a stock that has already rallied 10% over the past month and is now above the consensus target, the historical reaction pattern adds texture to why Goldman and others remain defensive.
The closest peer, MAN, fell 3.5% on Tuesday — the sharpest single-day drop among the staffing names — while KFY and KELY.A held up better on the week. RHI's 2.6% weekly gain is notably stronger than the peer group average, which makes the valuation stretch against consensus targets even more pronounced heading into July 24.
The key tension for next week's print is whether the cost discipline and Protiviti pipeline growth that underpin the bull case show up in numbers concrete enough to justify trading above the Street's mean target — or whether the bear case on Talent Solutions deterioration reasserts itself and gives the 22% short position reason to rebuild.
See the live data behind this article on ORTEX.
Open RHI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
